Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
RP-1828 IMMUcan
RP-1759 AYA/TYA
+2 more
Locations
134
Austria
Medical University Vienna - General Hospital AKH
Vienna, Austria
Onze Lieve Vrouw Ziekenhuis
Aalst, Belgium
ZAS Middelheim
Antwerp, Belgium
Hopitaux Universitaires - Institut Jules Bordet
Brussels, Belgium
Universitair Ziekenhuis Brussel
Brussels, Belgium
Cliniques Universitaires Saint-Luc
Brussels, Belgium
Start Date
May 3, 2017
Primary Completion Date
March 1, 2026
Completion Date
March 1, 2026
Last Updated
May 1, 2025
Lead Sponsor
European Organisation for Research and Treatment of Cancer - EORTC
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions